Form 8-K - Current report:
SEC Accession No. 0001193125-26-179401
Filing Date
2026-04-27
Accepted
2026-04-27 09:13:36
Documents
47
Period of Report
2026-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d138980d8k.htm   iXBRL 8-K 41626
2 EX-99.1 d138980dex991.htm EX-99.1 24489
3 EX-99.2 d138980dex992.htm EX-99.2 81993
7 GRAPHIC g138980g00z50.jpg GRAPHIC 211708
8 GRAPHIC g138980g00z51.jpg GRAPHIC 317218
9 GRAPHIC g138980g00z52.jpg GRAPHIC 93359
10 GRAPHIC g138980g00z53.jpg GRAPHIC 57417
11 GRAPHIC g138980g00z54.jpg GRAPHIC 72927
12 GRAPHIC g138980g00z55.jpg GRAPHIC 88620
13 GRAPHIC g138980g00z56.jpg GRAPHIC 110708
14 GRAPHIC g138980g00z57.jpg GRAPHIC 157825
15 GRAPHIC g138980g00z58.jpg GRAPHIC 42245
16 GRAPHIC g138980g00z59.jpg GRAPHIC 204352
17 GRAPHIC g138980g00z60.jpg GRAPHIC 141044
18 GRAPHIC g138980g00z61.jpg GRAPHIC 100126
19 GRAPHIC g138980g00z62.jpg GRAPHIC 191176
20 GRAPHIC g138980g00z63.jpg GRAPHIC 116351
21 GRAPHIC g138980g00z64.jpg GRAPHIC 209863
22 GRAPHIC g138980g00z65.jpg GRAPHIC 104587
23 GRAPHIC g138980g00z66.jpg GRAPHIC 108975
24 GRAPHIC g138980g00z67.jpg GRAPHIC 179230
25 GRAPHIC g138980g00z68.jpg GRAPHIC 157499
26 GRAPHIC g138980g00z69.jpg GRAPHIC 129764
27 GRAPHIC g138980g00z70.jpg GRAPHIC 119341
28 GRAPHIC g138980g00z71.jpg GRAPHIC 138097
29 GRAPHIC g138980g00z72.jpg GRAPHIC 151010
30 GRAPHIC g138980g00z73.jpg GRAPHIC 114767
31 GRAPHIC g138980g00z74.jpg GRAPHIC 74845
32 GRAPHIC g138980g00z75.jpg GRAPHIC 156348
33 GRAPHIC g138980g00z76.jpg GRAPHIC 166237
34 GRAPHIC g138980g00z77.jpg GRAPHIC 127357
35 GRAPHIC g138980g00z78.jpg GRAPHIC 95455
36 GRAPHIC g138980g00z79.jpg GRAPHIC 177282
37 GRAPHIC g138980g00z80.jpg GRAPHIC 107962
38 GRAPHIC g138980g00z81.jpg GRAPHIC 45843
39 GRAPHIC g138980g40v89.jpg GRAPHIC 11292
40 GRAPHIC g138980g79n57.jpg GRAPHIC 6682
  Complete submission text file 0001193125-26-179401.txt   6165528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ntla-20260427.xsd EX-101.SCH 3174
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20260427_lab.xml EX-101.LAB 17992
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20260427_pre.xml EX-101.PRE 11257
50 EXTRACTED XBRL INSTANCE DOCUMENT d138980d8k_htm.xml XML 3630
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 26896891
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)